These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 8395700)

  • 1. Retroperitoneal lymphadenectomy remains the treatment of choice in nonseminomatous germ cell tumors.
    Graham SD
    Semin Urol; 1993 May; 11(2):85-91. PubMed ID: 8395700
    [No Abstract]   [Full Text] [Related]  

  • 2. The case for observation of patients with clinical stage I nonseminomatous germ cell testicular tumors.
    Swanson DA
    Semin Urol; 1993 May; 11(2):92-8. PubMed ID: 7689741
    [No Abstract]   [Full Text] [Related]  

  • 3. Recurrence pattern and proposed surveillance protocol following post-chemotherapy retroperitoneal lymph node dissection.
    Spiess PE; Brown GA; Liu P; Tu SM; Tannir NM; Evans JG; Kamat AM; Kassouf W; Pisters LL
    J Urol; 2007 Jan; 177(1):131-8. PubMed ID: 17162023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surveillance versus nerve-sparing retroperitoneal lymphadenectomy in stage I nonseminomatous germ-cell tumors.
    Lowe BA
    Urol Clin North Am; 1993 Feb; 20(1):75-83. PubMed ID: 8381999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical management of early-stage nonseminomatous germ cell tumors of the testis.
    Lieskovsky G; Weinberg AC; Skinner DG
    Semin Urol; 1984 Nov; 2(4):208-16. PubMed ID: 6095395
    [No Abstract]   [Full Text] [Related]  

  • 6. Adjuvant chemotherapy for stage II nonseminomatous germ cell tumors.
    Kondagunta GV; Motzer RJ
    Urol Clin North Am; 2007 May; 34(2):179-85; abstract ix. PubMed ID: 17484923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retroperitoneal lymph node dissection in the treatment of low-stage nonseminomatous germ cell tumors of the testicle.
    Yoon GH; Stein JP; Skinner DG
    Expert Rev Anticancer Ther; 2005 Feb; 5(1):75-85. PubMed ID: 15757440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Retroperitoneal lymphadenectomy in testicular tumors].
    Mast GJ; Jung P; Moll V; Neisius D
    Chirurg; 1989 Mar; 60(3):148-52. PubMed ID: 2541979
    [No Abstract]   [Full Text] [Related]  

  • 9. Overview: treatment of local regional disease.
    Donohue JP
    Prog Clin Biol Res; 1990; 350():283-93. PubMed ID: 2166958
    [No Abstract]   [Full Text] [Related]  

  • 10. Reoperative retroperitoneal lymph node dissection for metastatic germ cell tumors: analysis of local recurrence and predictors of survival.
    Pedrosa JA; Masterson TA; Rice KR; Bihrle R; Beck SD; Foster RS
    J Urol; 2014 Jun; 191(6):1777-82. PubMed ID: 24518787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic and therapeutic significance of retroperitoneal lymph node dissection in low stage and localized disease: point of view.
    Whitmore WF
    Prog Clin Biol Res; 1985; 203():263-8. PubMed ID: 3008179
    [No Abstract]   [Full Text] [Related]  

  • 12. Retroperitoneal lymph node dissection in testicular cancer.
    Jacobsen NE; Foster RS; Donohue JP
    Surg Oncol Clin N Am; 2007 Jan; 16(1):199-220. PubMed ID: 17336244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends of retroperitoneal lymphadenectomy use in patients with nonseminomatous germ cell tumor of the testis: a population-based study.
    Sun M; Abdollah F; Budaüs L; Liberman D; Tian Z; Morgan M; Johal R; Schmitges J; Shariat SF; Montorsi F; Greafen M; Perrotte P; Karakiewicz PI
    Ann Surg Oncol; 2011 Oct; 18(10):2997-3004. PubMed ID: 21509630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complications of primary nerve sparing retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumors of the testis: experience of the German Testicular Cancer Study Group.
    Heidenreich A; Albers P; Hartmann M; Kliesch S; Kohrmann KU; Krege S; Lossin P; Weissbach L;
    J Urol; 2003 May; 169(5):1710-4. PubMed ID: 12686815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of primary tumor size and preorchiectomy serum tumor marker level in predicting pathologic stage at retroperitoneal lymph node dissection in clinical Stage A nonseminomatous germ cell tumors.
    Beck SD; Foster RS; Bihrle R; Donohue JP
    Urology; 2007 Mar; 69(3):557-9. PubMed ID: 17382165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Editorial comment on: laparoscopic retroperitoneal lymph node dissection: does it still have a role in the management of clinical stage I nonseminomatous testis cancer? A European perspective.
    Pizzocaro G
    Eur Urol; 2008 Nov; 54(5):1017-8. PubMed ID: 18722705
    [No Abstract]   [Full Text] [Related]  

  • 17. Editorial comment on: laparoscopic retroperitoneal lymph node dissection: does it still have a role in the management of clinical stage I nonseminomatous testis cancer? A European perspective.
    Mottet N
    Eur Urol; 2008 Nov; 54(5):1018-9. PubMed ID: 18722702
    [No Abstract]   [Full Text] [Related]  

  • 18. Editorial comment on: laparoscopic retroperitoneal lymph node dissection: does it still have a role in the management of clinical stage I nonseminomatous testis cancer? A European perspective.
    Albers P
    Eur Urol; 2008 Nov; 54(5):1016-7. PubMed ID: 18722703
    [No Abstract]   [Full Text] [Related]  

  • 19. Editorial comment on: laparoscopic retroperitoneal lymph node dissection: does it still have a role in the management of clinical stage I nonseminomatous testis cancer? A European perspective.
    Fornara P; Hoda MR
    Eur Urol; 2008 Nov; 54(5):1015-6. PubMed ID: 18722706
    [No Abstract]   [Full Text] [Related]  

  • 20. Primary retroperitoneal lymph node dissection in patients with clinical stage IS testis cancer.
    Williams SB; Steele GS; Richie JP
    J Urol; 2009 Dec; 182(6):2716-20. PubMed ID: 19836777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.